MainStreet Investment Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.78M | Sell |
43,677
-870
| -2% | -$83.3K | 0.57% | 45 |
|
|
2025
Q4 | $4.28M | Sell |
44,547
-3,470
| -7% | -$337K | 0.62% | 42 |
|
|
2025
Q3 | $4.57M | Sell |
48,017
-740
| -2% | -$68K | 0.61% | 44 |
|
|
2025
Q2 | $4.25M | Sell |
48,757
-620
| -1% | -$52.6K | 0.59% | 46 |
|
|
2025
Q1 | $4.44M | Sell |
49,377
-1,006
| -2% | -$90K | 0.65% | 41 |
|
|
2024
Q4 | $4.02M | Sell |
50,383
-1,443
| -3% | -$125K | 0.56% | 47 |
|
|
2024
Q3 | $4.67M | Sell |
51,826
-1,591
| -3% | -$134K | 0.62% | 43 |
|
|
2024
Q2 | $4.2M | Buy |
53,417
+66
| +0.1% | +$5.41K | 0.51% | 52 |
|
|
2024
Q1 | $4.65M | Sell |
53,351
-1,448
| -3% | -$124K | 0.56% | 52 |
|
|
2023
Q4 | $4.51M | Sell |
54,799
-6,047
| -10% | -$461K | 0.51% | 52 |
|
|
2023
Q3 | $4.77M | Sell |
60,846
-1,734
| -3% | -$145K | 0.56% | 46 |
|
|
2023
Q2 | $5.51M | Sell |
62,580
-1,406
| -2% | -$121K | 0.6% | 44 |
|
|
2023
Q1 | $5.16M | Buy |
63,986
+3,105
| +5% | +$253K | 0.56% | 45 |
|
|
2022
Q4 | $4.73M | Sell |
60,881
-6,026
| -9% | -$488K | 0.53% | 51 |
|
|
2022
Q3 | $5.4M | Sell |
66,907
-9
| -0% | -$809 | 0.66% | 43 |
|
|
2022
Q2 | $6.01M | Sell |
66,916
-835
| -1% | -$84.6K | 0.69% | 44 |
|
|
2022
Q1 | $7.52M | Sell |
67,751
-502
| -0.7% | -$53K | 0.7% | 41 |
|
|
2021
Q4 | $7.06M | Sell |
68,253
-377
| -0.5% | -$43.7K | 0.62% | 44 |
|
|
2021
Q3 | $8.6M | Sell |
68,630
-1,054
| -2% | -$136K | 0.83% | 30 |
|
|
2021
Q2 | $8.65M | Buy |
69,684
+153
| +0.2% | +$19.2K | 0.74% | 36 |
|
|
2021
Q1 | $8.21M | Sell |
69,531
-1,614
| -2% | -$189K | 0.68% | 42 |
|
|
2020
Q4 | $8.33M | Sell |
71,145
-3,443
| -5% | -$379K | 0.66% | 42 |
|
|
2020
Q3 | $7.75M | Buy |
74,588
+7,725
| +12% | +$776K | 0.61% | 46 |
|
|
2020
Q2 | $6.13M | Sell |
66,863
-11,525
| -15% | -$1.11M | 0.42% | 43 |
|
|
2020
Q1 | $7.07M | Buy |
78,388
+9,360
| +14% | +$996K | 0.87% | 30 |
|
|
2019
Q4 | $7.83M | Buy |
69,028
+5,107
| +8% | +$560K | 0.86% | 33 |
|
|
2019
Q3 | $6.94M | Buy |
63,921
+502
| +0.8% | +$52.4K | 0.91% | 32 |
|
|
2019
Q2 | $6.18M | Buy |
63,419
+2,860
| +5% | +$261K | 0.81% | 36 |
|
|
2019
Q1 | $5.51M | Buy |
60,559
+2,488
| +4% | +$223K | 0.78% | 37 |
|
|
2018
Q4 | $5.28M | Buy |
58,071
+155
| +0.3% | +$14.5K | 0.82% | 35 |
|
|
2018
Q3 | $5.7M | Sell |
57,916
-100
| -0.2% | -$9.24K | 0.77% | 38 |
|
|
2018
Q2 | $4.97M | Buy |
58,016
+2,006
| +4% | +$168K | 0.72% | 40 |
|
|
2018
Q1 | $4.49M | Buy |
56,010
+1,360
| +2% | +$112K | 0.69% | 39 |
|
|
2017
Q4 | $4.41M | Buy |
+54,650
| New | +$4.38M | 0.68% | 41 |
|
Other funds holding MDT
VCM
VPM
MainStreet Investment Advisors's MDT Position: Q1 2026 in Review
MainStreet Investment Advisors reduced its Medtronic (MDT) stake by 2% in Q1 2026, selling an estimated $83.3K and leaving 43,677 shares worth $3.78M. The position accounts for 0.57% of the portfolio, ranked #45.
MainStreet Investment Advisors first reported a position in MDT in Q4 2017 and has held it in 34 quarters since. The position peaked at $8.65M in Q2 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- MainStreet Investment Advisors held 43,677 shares of Medtronic worth $3.78M as of Q1 2026.
- MainStreet Investment Advisors sold 870 Medtronic shares in Q1 2026, an estimated $83.3K.
- Medtronic made up 0.57% of MainStreet Investment Advisors's portfolio in Q1 2026, its #45 holding.
- MainStreet Investment Advisors first reported a position in Medtronic in Q4 2017 and has held it in 34 quarters since.
- MainStreet Investment Advisors's Medtronic position peaked at $8.65M in Q2 2021.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on MainStreet Investment Advisors's 13F filing for Q1 2026, filed 11 May 2026.